Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China · Delayed Price · Currency is CNY 16.33
-0.23 (-1.39%)
May 21, 2026, 3:04 PM CST
SHE:002932 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -13.18 | -16.46 | 74.52 | 74.93 | 4,208 | 1,413 |
Depreciation & Amortization | 54.38 | 54.38 | 62.98 | 83.4 | 59.08 | 23.63 |
Other Amortization | 1.02 | 1.02 | 14.51 | 11.82 | 2.65 | 0.87 |
Loss (Gain) From Sale of Assets | -0.66 | -0.66 | -1.79 | -0.31 | -0.01 | - |
Asset Writedown & Restructuring Costs | 78.35 | 78.35 | 91.01 | -4.58 | 646.56 | 21.33 |
Loss (Gain) From Sale of Investments | -103.96 | -103.96 | -135.44 | -125.14 | -37.88 | -0.67 |
Other Operating Activities | -56.18 | -56.65 | -47.28 | 3.29 | 153.33 | 34.62 |
Change in Accounts Receivable | 176.21 | 176.21 | 411.72 | 1,256 | -2,325 | -722.32 |
Change in Inventory | 35.31 | 35.31 | 84.76 | 342.82 | -473.38 | -166.86 |
Change in Accounts Payable | -244.39 | -244.39 | -644.14 | -1,302 | 1,539 | 530.21 |
Change in Other Net Operating Assets | - | - | - | 79.95 | 370.01 | - |
Operating Cash Flow | -66.29 | -70.05 | -85.05 | 392.5 | 4,013 | 1,127 |
Operating Cash Flow Growth | - | - | - | -90.22% | 256.06% | 213.33% |
Capital Expenditures | -62.61 | -90.89 | -184.77 | -109.97 | -313.38 | -103.57 |
Sale of Property, Plant & Equipment | 4.83 | 4.17 | 0.78 | 0.15 | - | - |
Divestitures | 0.84 | 0.84 | - | - | - | - |
Investment in Securities | 653.32 | 449.65 | 28.04 | -1,290 | -1,958 | -588 |
Other Investing Activities | 255.32 | 66.15 | 17.82 | 34.71 | 37.18 | 6.45 |
Investing Cash Flow | 837.29 | 429.91 | -138.12 | -1,365 | -2,234 | -685.12 |
Short-Term Debt Issued | - | - | 3 | 23.61 | 137.39 | 30 |
Long-Term Debt Issued | - | 1.95 | 18.88 | - | - | - |
Total Debt Issued | 4.95 | 1.95 | 21.88 | 23.61 | 137.39 | 30 |
Short-Term Debt Repaid | - | -3 | -23.61 | -125 | -53.42 | -141.5 |
Long-Term Debt Repaid | - | -3.45 | -6 | -20.49 | -4.72 | -2.95 |
Total Debt Repaid | -6.45 | -6.45 | -29.61 | -145.49 | -58.14 | -144.45 |
Net Debt Issued (Repaid) | -1.49 | -4.49 | -7.74 | -121.87 | 79.24 | -114.45 |
Issuance of Common Stock | - | - | - | - | - | 482.71 |
Repurchase of Common Stock | -10.01 | -10.01 | -238.16 | -0.53 | - | - |
Common Dividends Paid | -263.23 | -263.26 | -34.19 | -582.48 | -550.64 | -283.39 |
Other Financing Activities | 8.18 | -6.59 | -33.08 | 34.83 | 38.6 | -2.6 |
Financing Cash Flow | -266.55 | -284.35 | -313.17 | -670.06 | -432.79 | 82.27 |
Foreign Exchange Rate Adjustments | -2.62 | -1.55 | 0.51 | 1.26 | 19.47 | -3.2 |
Net Cash Flow | 501.83 | 73.95 | -535.83 | -1,641 | 1,365 | 520.96 |
Free Cash Flow | -128.9 | -160.95 | -269.81 | 282.52 | 3,699 | 1,023 |
Free Cash Flow Growth | - | - | - | -92.36% | 261.47% | 208.82% |
Free Cash Flow Margin | -48.50% | -60.72% | -77.08% | 37.69% | 35.13% | 36.17% |
Free Cash Flow Per Share | - | -0.68 | -1.20 | 1.24 | 16.09 | 4.84 |
Cash Income Tax Paid | 14.77 | 14.77 | 4.45 | 268.9 | 1,253 | 219.86 |
Levered Free Cash Flow | -1,059 | -225.37 | -178.98 | 384.35 | 2,660 | 631.65 |
Unlevered Free Cash Flow | -1,059 | -225.09 | -178.17 | 390.91 | 2,662 | 632.97 |
Change in Working Capital | -26.07 | -26.07 | -143.56 | 349.09 | -1,019 | -365.99 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.